Wegovy and Ozempic are both weight loss drugs that belong to the GLP-1 agonist class of medications. Wegovy is a new medication that was approved by the FDA in June 2021, while Ozempic has been available since December 2017 [1].

According to GoodRx, the cost of Wegovy and Ozempic can vary depending on factors such as dosage, location, and insurance coverage. However, as of September 2021, the average retail price for a 2-week supply of Wegovy is $1,380, while the average retail price for a 2-week supply of Ozempic is $1,400 [3].

UCHealth notes that both medications are typically prescribed for patients with a body mass index (BMI) of 30 or higher, or for patients with a BMI of 27 or higher who also have at least one weight-related health condition such as high blood pressure or type 2 diabetes [2].

It is important to note that the cost of these medications may be covered by insurance, and patients should consult with their healthcare provider and insurance provider to determine their out-of-pocket costs. Additionally, there may be alternative weight loss medications or lifestyle changes that can be effective for some patients and may be more affordable [2].

In summary, the cost of Wegovy and Ozempic can vary depending on several factors, but as of September 2021, the average retail price for a 2-week supply of Wegovy is slightly lower than that of Ozempic. Patients should consult with their healthcare provider and insurance provider to determine their out-of-pocket costs and consider alternative options for weight loss.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.uchealth.org/today/wegovy-vs-ozempic-the-truth-about-new-weight-loss-drugs/
[3] https://www.goodrx.com/classes/glp-1-agonists/wegovy-vs-ozempic